4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011831
Chief Financial Officer sold 8,000 shares at $18.00 ($144,000)
- Chief Financial Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-19 | Exercise or conversion : show line 1 in the form | +8,000 | $5.20 | $41,600 | 313,607 | D |
| 2019-02-19 | Sale : show line 2 in the form | −8,000 | $18.00 | $144,000 | 305,607 | D |
| Open-market sales · 8,000 sh · avg $18.00 · $144,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-19 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −8,000 | 235,000 | D |
Loading xslF345X03/doc4.xml…